Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2010 Mar 11;16(9):1399–1404. doi: 10.1111/j.1469-0691.2010.03147.x

Impact of bacterial colonization on the severity, and accompanying airway inflammation, of virus‐induced wheezing in children

D Yu 1, L Wei 2, L Zhengxiu 1, L Jian 1, W Lijia 3, L Wei 3, Y Xiqiang 4, Z Xiaodong 4, F Zhou 1, L Enmei 1
PMCID: PMC7128791  PMID: 20041894

Abstract

Clin Microbiol Infect 2010; 16: 1399–1404

Abstract

It is reported that bacterial colonization of the airway in neonates affects the likelihood and severity of subsequent wheezing in childhood. This study aimed to explore the impact of bacterial colonization on the severity of virus‐induced wheezing, and accompanying airway inflammation. Nasopharyngeal aspirates (NPAs) from 68 hospitalized children with bronchiolitis and 85 children with recurrent wheezing were obtained. Eleven common respiratory viruses were sought by PCR and/or direct fluorescence assay. Bacteria were isolated from NPAs by routine culture methods. Cell numbers and concentrations of cytokines/chemokines in the NPAs were measured, and nucleated cells were characterized. The frequency of bacterial colonization in children with recurrent wheezing was significantly higher than in children with an initial attack of bronchiolitis. Bacterial colonization accompanying virus infection had no effect on clinical manifestations, duration of hospitalization, concentrations of cytokines/chemokines (except interleukin‐10 (IL‐10)) or cellularity in the children with bronchiolitis; however, among the children with recurrent wheezing, those who had coexistent non‐invasive bacterial colonization and virus infection presented more frequent cyanosis, longer duration of hospitalization, a higher concentration of IL‐10 and a higher percentage of neutrophils in NPAs than those with virus infection but without bacterial colonization. Bacterial colonization was common in children with virus‐induced wheezing, particularly in the situation of recurrent wheezing. To some extent, bacterial colonization accompanying virus infection may contribute to the severity of the wheezing because of its impact on airway inflammation.

Keywords: Airway inflammation, bacterial colonization, bronchiolitis, recurrent wheezing, virus infection

Introduction

The nasopharynx may be densely colonized by a broad variety of microorganisms, including commensal bacteria and potential pathogens such as Streptococcus pneumoniae, Haemophilus influenzae (essentially non‐typeable strains) and Moraxella catarrhalis. In most cases, these organisms are carried without causing clinical symptoms.

It has been reported that up to 88% of cases of wheezing in children are associated with respiratory virus infections [1]. A previous investigation showed that acute viral wheezing in children was often associated with bacterial upper respiratory tract infections, such as otitis media and sinusitis, but blood leukocyte counts and C‐reactive protein (CRP) levels were generally not raised. [2]. It has also been suggested that, in synergy with respiratory viral infection, bacterial colonization may contribute to respiratory inflammation. Bisgard et al. [3] reported that neonates who had S. pneumoniae, H. influenzae or M. catarrhalis, or a combination of these organisms, colonizing the hypopharyngeal region were at increased risk of recurrent wheezing and asthma early in life [4]. This result might indicate that such bacterial colonization in neonates is not a neutral matter but plays a critical role in infantile wheezing.

In this study, we aimed to assess the relationships among bacterial colonization, virus infection and infantile wheezing. To achieve this, the clinical characteristics and also the cellularity and cytokine/chemokine levels of nasopharyngeal aspirates were compared between two groups of children who had virus‐induced wheezing, and between those in each group with bacterial colonization and those without.

Materials and Methods

Research subjects and sample collection

From November 2006 to March 2008, 68 children with bronchiolitis and 85 with recurrent wheezing, who were hospitalized in the Department of Respiratory Medicine, Children’s Hospital, Chongqing Medical University, were enrolled in this study. The study protocol was approved by the Institutional Review Boards of the hospital, and written informed consent of a parent or legal guardian was obtained before the infants were enrolled. Bronchiolitis was defined as the first episode of acute expiratory wheezing in a child <3 years of age. Recurrent wheezing was characterized as daily symptoms for at least four consecutive weeks: all of the children in this group were taking inhaled bronchodilators and corticosteroids without relief.

Immediately following hospital admission, nasopharyngeal aspirates (NPAs) were prospectively collected from all subjects, and venous blood was taken for determination of total leukocyte count and CRP level. Blood culture was performed when NPA culture was positive. Positive blood culture in patients with a CRP concentration of >80 mg/L or a white blood cell count of >15.0 × 109/L was considered to represent true bacterial infection, and these patients were excluded. All children were examined by one of two study physicians twice daily during hospitalization. Signs and symptoms were recorded on a standard form used in our hospital. Children were discharged from hospital after the wheezing improved or was cured. Severity was determined on the basis of clinical symptoms and the duration of hospitalization.

NPA analysis

After NPA was collected, it was gently aspirated with a Pasteur pipette and then expelled repeatedly until mixed uniformly: 0.5 mL of the specimen was then transferred to another tube for cellular identification and cytokine estimation. To this sample, about four times its volume of 0.1% dithiothreitol was added, and the whole was mixed with a Pasteur pipette, vortexed for 15 s, and rocked on a bench rocker for 15 min. The suspension was subsequently filtered through 48‐μm nylon gauze to remove mucus and debris without removing any of the cells, and then centrifuged at 1500 r.p.m. for 10 min. The cell‐free supernatant was stored at −80°C. The cell pellet was resuspended, and the total cell count was determined with a Neubauer haemocytometer. The Trypan blue exclusion method was used to determine cell viability, blue cells being considered to be non‐viable. Differential cell counts were obtained using a modified version of Wright staining (Liu A and Liu B solution, Baso, Zhuhai, China) and cytocentrifuged smears of the NPA cell suspensions. At least 400 cells were examined by the same observer in each specimen. Cell counts are expressed as multiples of 105/mL; results are presented as means and standard deviations.

Viral antigen detection, culture for bacteria and fungi and cellular identification were performed immediately, and the samples prepared for PCR assays and cytokine estimation were stored in tubes at −80°C before processing.

Detection of bacteria and yeasts

Qualitative and semiquantitative cultures for bacteria and yeasts were performed using standard microbiological methods [5, 6]. For all samples, macroscopically distinct colonies were isolated in pure culture, and standard methods for identification, typing and establishing antibiotic sensitivity patterns were used.

Respiratory virus detection

RNA was extracted from 140 μL of the NPA using the QIAamp Virus RNA Mini kit (Qiagen, MD, USA), and eluted in 60 μL of RNase‐free water. DNA was extracted from 200 μL of NPA using the QIAamp DNA mini kit (Qiagen) and was eluted in 200 μL of AE buffer. Viral antigens were detected for adenovirus, influenza A virus, influenza B virus, parainfluenza virus 1, 2 and 3 and respiratory syncytial virus (RSV) by direct fluorescent assay (D3 DFA Respiratory Viruses Screening & ID Kit; Diagnostic Hybrids, Hannover, Germany). PCR was used for the detection of adenovirus and human bocavirus. RT‐PCR was used for the detection of rhinoviruses, RSV, human coronaviruse OC43, influenza A virus, influenza B virus, parainfluenza virus 1–3 and human metapneumovirus. Reverse transcription of 0.5 mg of each RNA was performed in a final volume of 10 μL containing 25 pmol of Oligo dT primer and 50 pmol of random 6 mers, 5 × PrimeScript Buffer, and 0.5 μL of PrimeScript RT Enzyme Mix (TaKaRa, Dalian, China). Amplification was performed with a Bio‐Rad thermal cycler, using commercially available master mixes (Promega, Madison, WI, USA) and standard protocols. All PCR assays were performed using 2 μL of cDNA and 1 mM each primer. The primer sequences, PCR protocols and other viral detection methods are shown in Table 1. The unclassified rhinoviruses were not identified further. A specimen was regarded as positive if either one or two methods gave positive results.

Table 1.

 Primers used in PCR

Virus Primer Sequence References
HBoV NP‐1 188F 5′‐GAGCTCTGTAAGTACTATTAC‐3′ [7]
542R 5′‐CTCTGTGTTGACTGAATACAG‐3′
NS1HBoV01 5′‐TATGGCCAAGGCAATCGTCCAAG‐3′ [8]
2 HBoV02.2 5′‐GCCGCGTGAACATGAGAAACAGA‐3′
hMPV F‐gene (forward) 5′‐GCAACAATTGAACTGATCTTCAGGAAAC‐3′ [9]
F‐gene (reverse) 5′‐GCAACATTGAACTGATCTTCAGGAAAC‐3′
F‐gene (forward) 5′‐ACATGCCAACATCTGCAGGACAAATAAAAC‐3′
F‐gene (reverse) 5′‐ACATGCTGTTCACCTTCAACTTTGC‐3′
RV 5′‐Noncoding 5′‐CGGACACCCAAAGTAG‐3′ [10]
5′‐GCACTTCTGTTTCCCC‐3′
HCoV Nucleoprotein 5′‐TGCAAAGATGGGGAACTGTGGG‐3′ [10]
OC43 5′‐AGGAAGGTCTGCTCCTAATTCC‐3′
Flu A Matrix 5′‐CAGAGACTTGAAGATGTCTTTGC‐3′ [10]
5′‐GCTCTGTCCATGTTATTTGGATC‐3′
Flu B Matrix 5′‐GAAAAATTACACTGTTGGTTCGGTG‐3′ [10]
5′‐AGCGTTCCTAGTTTTACTTGCATTGA‐3′
PIV 1 HN gene 5′‐ATTTCTGGAGATGTCCCGTAGGAGAA C‐3′ [11]
5′‐CACATCCTTGAGTGATTAAGTTTGATG‐3′
PIV 3 HN gene 5′‐CTCGAGGTTGTCAGGATATAG‐3′ [12]
5′‐CTTTGGGAGTTGAACACAGTT‐3′
RSV Nucleoprotein 5′‐TGGGACACTCTTAATCAT‐3′ [13]
5′‐TGATTCCAAGCTGAGGAT‐3′
5′‐GTTGTAGGTGTGTTTC‐3′

Flu A, influenza A virus; Flu B, influenza B virus; HBoV, human bocavirus; HCoV, human coronavirus; hMPV, human metapneumovirus; PIV, parainfluenza virus; RSV, respiratory syncytial virus; RV, rhinovirus.

Cytokine/chemokine analysis

According to the manufacturer’s instructions, NPAs were tested by ELISA (BD Pharmingen, San Diego, CA, USA) for interleukin‐6 (IL‐6), interleukin‐8, interleukin‐10 (IL‐10) and monocyte chemoattractant protein‐1. Each sample was measured in duplicate by Varioskan Flash (Thermo), according to the kit’s directions. The concentration of each cytokine in NPA was determined by interpolation from the corresponding standard curve. When values were below the detection threshold, the minimum detectable level was assigned.

Statistical analysis

Differences in continuous variables or proportions were tested using t‐test, one‐way ANOVA or chi‐square test, or Fisher’s exact, where appropriate. Non‐parametric tests and median values were used for those variables, such as cell count and cytokine/chemokine concentrations, that were not normally distributed. Correlations were made with Spearman’s two‐tailed rank correlation in addition to Pearson’s linear regression two‐tailed analysis. Two‐tailed p <0.05 was considered to be statistically significant. SPSS (version 13.0, Chicago, IL, USA) was used for all analyses.

Results

Microbiological results

Participating in this study were 68 children in the bronchiolitis group, aged from 4 to 30 months, with a median age of 7.15 ± 0.5 months, 49 of whom (72.06%) were male, and 85 children with recurrent wheezing, aged from 3 to 30 months, with a median age of 8.34 ± 0.54 months, 60 of whom (70.58%) were male (Table 2).

Table 2.

 Demographic and epidemiological characteristics of children with bronchiolitis and with recurrent wheezing

Variable Bronchiolitis (n = 68) Recurrent wheezing (n = 85) p
Age (mean ± SEM) (months) 7.15 ± 0.50 (range: 4–30) 8.34 ± 0.54 (range:2–30) 0.11
Male sex 49/68 60/85 0.86
Family history of atopy 47/68 49/85 0.18
Duration of hospitalization (days) 7.81 ± 0.36 14.58 ± 0.83 <0.0001

SEM, standard error of the mean.

Table 3 shows the detection rate for viruses and bacterial colonization in the two groups. Among the children with bronchiolitis, one virus was detected in 29 samples (42.65%) and two or more viruses in 27 samples (39.71%). RSV was the most frequenly detected virus. One species of bacterium was found in 29 samples (42.65%), and more than one species in nine samples (13.24%). H. influenzae, Haemophilus parainfluenzae and Klebsiella pneumoniae were the most frequently detected bacteria. Among the children with recurrent wheezing, one virus was found in 32 samples (37.65%), and more than one was detected in 31 samples (36.47%). Human bocavirus was the most frequently detected virus. One bacterial species was found in 49 samples (57.65%), and more than one in 21 samples (24.71%). In this group, S. pneumoniae, H. influenzae and K. pneumoniae were most frequently detected. The frequency of bacterial colonization in children with recurrent wheezing was significantly higher than in children with bronchiolitis. However, the frequency of simultaneous bacterial colonization and virus infection in the two groups was not significantly different.

Table 3.

 Microorganism detection in children with bronchiolitis and children with recurrent wheezing

Microorganism detection Bronchiolitis (n = 68), n (%) Recurrent wheezing (n = 85), n (%) p
Virus detection 56 (82.35) 63 (74.12) 0.246
Single virus‐positive 29 (42.65) 32 (37.65) 0.619
 RSV 22 (32.35) 5 (5.88) <0.01
 PIV 3 4 (5.88) 7 (8.24) 0.756
 RV 2 (2.94) 3 (3.53) 1
PIV 1 1 (1.47) 0 (0)
 HBoV 0 (0) 11 (12.94)
 Flu A 0 (0) 6 (7.06)
More than one virus‐positive 27 (39.71) 31 (36.47) 0.739
Bacterial colonization 38 (55.88) 70 (82.35) 0.001
 Single species present 29 (42.65) 49 (57.65) 0.075
 Streptococcus pneumoniae 2 (2.94) 7 (8.24) 0.3
 Haemophilus influenzae 7 (10.29) 6 (7.06) 0.565
 Haemophilus parainfluenzae 5 (7.35) 8 (9.41) 0.774
 Klebsiella pneumoniae 3 (4.41) 13 (15.29) 0.034
 Moraxella catarrhalis 2 (2.94) 2 (2.35) 1
 Other bacteria 10 (14.71) 13 (15.29) 1
More than one species 9 (13.24) 21 (24.71) 0.101
Virus‐positive with bacterial colonization 30 (44.11) 50 (58.82) 0.076

Flu A, influenza A virus; HBoV, human bocavirus; PIV, parainfluenza virus; RSV, respiratory syncytial virus; RV, rhinovirus.

Clinical characteristics of children with virus infection, with or without bacterial colonization (Table 4)

Table 4.

 Clinical characteristics of children who had virus infection with or without bacterial colonization

Variable Bronchiolitis with viral detection Recurrent wheezing with viral detection
Bacteria‐positive (n = 30) Bacteria‐negative (n = 26) Bacteria‐positive (n = 50) Bacteria‐negative (n = 13)
Clinical symptoms
 Cough 30 (100) 26 (100) 50 (100) 13 (100)
 Fever 6 (20) 5 (19.23) 20 (40) 4 (30.77)
 Rhinorrhoea 4 (13.33) 4 (15.38) 14 (28) 4 (30.77)
 Vomiting 1 (3.33) 2 (7.69) 7 (14) 1 (7.69)
 Shortness of breath 3 (10) 0 11 (22) 3 (23.08)
 Diarrhoea 15 (50) 11 (42.31) 12 (24) 1 (7.69)
 Rapid breathing 9 (30) 4 (15.38) 17 (34) 3 (23.08)
 Cyanosis 14 (46.67) 6 (23.08) 19 (38)a 1 (7.69)a
 Atopy 21 (70) 18 (69.23) 34 (68) 7 (53.85)
Duration of hospitalization (days)b 7.57 ± 0.57 7.92 ± 0.57 18.18 ± 2.03c 14.32 ± 1.00c
White blood cell countb (101 cell/mL) 9.52 ± 0.57 9.90 ± 1.16 10.26 ± 0.55 9.50 ± 0.69

Note: Data are no. (%) of children.

aCalculated using Fisher’s exact test. p 0.047 (considered to indicate statistical significance).

bDuration of hospitalization is presented as mean ± standard deviation.

cCalculated using the Mann–Whitney U‐test. p 0.0379 (considered to indicate statistical significance).

Among the children with bronchiolitis, the two groups (with and without bacterial colonization) were similar in all clinical manifestations and duration of hospitalization. Among the children with recurrent wheezing, the two groups were similar in all clinical manifestations except cyanosis, but children who had virus infection with bacterial colonization had a significantly longer duration of hospitalization.

Cell counts and cytokine/chemokine concentrations (Table 5)

Table 5.

 Cellular content and cytokine/chemokine concentrations of nasopharyngeal aspirates (NPAs) in children who had virus infection with or without bacterial colonization

Variable Bronchiolitis with viral detection Recurrent wheezing with viral detection
Bacteria‐positive (n = 30) Bacteria‐negative (n = 26) Bacteria‐positive (n = 50) Bacteria‐negative (n = 13)
Cytokine/chemokine (pg/mL)
 IL‐8 1682 ± 462.5 1726 ± 427.7 2757 ± 1203 2213 ± 809.4
 IL‐6 14.9 ± 6.1 56.1 ± 42.3 44.5 ± 25.7 44.2 ± 10.6
 IL‐10 30.7 ± 8.0a 62.5 ± 24.1a 133.6 ± 55.4b 47.9 ± 10.8b
 MCP‐1 14.5 ± 1.6 9.6 ± 2.0 13.5 ± 11.1 3.5 ± 1.1
Absolute number of cells in NPA (×105/mL)
 Total number 20.60 ± 7.03 29.72 ± 6.50 68.57 ± 19.92 38.10 ± 19.60
Percentages of cell types in nucleated cells of NPA
 Macrophage 23.61 ± 5.40 19.91 ± 4.68 26.73 ± 6.86c 40.71 ± 3.92c
 Lymphocyte 1.15 ± 0.37 1.35 ± 0.75 2.96 ± 0.90 8.04 ± 1.94
 Neutrophil 64.43 ± 5.70 68.04 ± 6.19 60.73 ± 7.81d 43.66 ± 4.67d

Note: All data are presented as mean ± standard deviation.

IL, interleukin; MCP, monocyte chemoattractant protein.

aCalculated using the Mann–Whitney U‐test. p 0.0452 (considered to indicate statistical significance).

bCalculated using the Mann–Whitney U‐test. p 0.0161 (considered to indicate statistical significance).

cCalculated using the Mann–Whitney U‐test. p 0.0408 (considered to indicate statistical significance).

dCalculated using the Mann–Whitney U‐test. p 0.0106 (considered to indicate statistical significance).

Among the children with bronchiolitis, concentrations of cytokines/chemokines and cellularity in NPA were not significantly different between the two groups, except in the case of IL‐10, the level of which was higher in the bacteria‐negative group. In the children with recurrent wheezing, a higher concentration of IL‐10 and a higher percentage of neutrophils were found in those who had virus infection with bacterial colonization than in children who had virus infection without bacterial colonization, whereas the percentage of macrophages was lower in the former group.

Discussion

Previous studies have shown that bacterial colonization of the upper respiratory tract is common throughout infancy [14, 15, 16, 17, 18]. In one investigation of monthly nasopharyngeal cultures taken from healthy infants from the time of birth, 78% were found to have bacterial colonization during the first 2 years of life [15]. The clinical significance of bacterial colonization has been disputed in the various reports. It is widely accepted that viral infections [19] and bacterial upper respiratory tract infections [20] can exacerbate symptoms of asthma. However, observations in chronic obstructive pulmonary disease patients have suggested that isolation of bacteria from sputum during exacerbations represents chronic colonization, which is an innocent bystander role for the bacteria [21, 22, 23]. In most cases, colonization persists for weeks to months without symptoms [24, 25], but the bacteria may spread contiguously to produce local respiratory tract disease. Even during colonization, bacteria in these airways are in a constant state of turnover, releasing extracellular products, and undergoing lysis with release of a variety of proteins, lipo‐oligosaccharides and peptidoglycans [26]. Bacterial products in the airways may be potent stimuli for neutrophil migration thither, and elastase released from these neutrophils can act synergistically with bacterial products and cause further inhibition of tracheobronchial ciliary function.

In this study, we found that many of the children with virus‐induced wheezing had nasopharyngeal bacterial colonization, and this proportion was higher among children with recurrent wheezing. In the children with bronchiolitis, although concentrations of IL‐10 were different in the two groups of children, all clinical manifestations and duration of hospitalization were similar. The predominant cells in the airway in RSV bronchiolitis are neutrophils. Activation of innate immunity against the virus by the promotion of proinflammatory mediators, such as IL‐6, IL‐10 and monocyte chemoattractant protein‐1, and cytokines such as IL‐6 and interleukin‐8, correlates with disease severity [27, 28, 29]. A previous study indicated that bacterial colonization did not add specific symptoms to the clinical signs already present in RSV bronchiolitis, except that, in patients with severe disease, those with bacterial colonization required ventilation for a longer period [30]. Our data indicate that coexisting non‐invasive bacterial colonization has little impact on the severity of an attack of virus‐induced bronchiolitis.

However, in the children with recurrent wheezing, a higher frequency of cyanosis and a longer duration of hospitalization were found in children in whom bacterial colonization accompanied virus infection. Moreover, the concentration of IL‐10 and percentage of neutrophils were similarly found to differ between these two groups. Previous studies have demonstrated increased numbers of macrophages and neutrophils in bronchoalveolar lavage from young children with severe recurrent wheezing [31]. The concentration of IL‐10 was found to be four times that of CXCL‐8 and 140 times that of CCL‐3 in the airways of infants with severe wheezing disease. IL‐10 acts to recruit monocytes into the lung to help the phagocytosis of apoptotic neutrophils [32]. These data suggest that coincident non‐invasive bacterial colonization and virus infection might have contributed to the severity and persistence of wheezing in the children with recurrent wheezing.

In conclusion, this study provides further evidence that coexisting non‐invasive bacterial colonization in children with virus‐induced wheezing is common, in particular in those with recurrent wheezing. To some extent, coexisting non‐invasive bacterial colonization with virus infection might contribute to the severity of recurrent wheezing because of its impact on airway inflammation.

Transparency Declaration

The original studies were approved by the Institutional Review Boards of the hospital and supported by the Program for New Century Excellent Talents in Universities (No. NCET‐06‐0775) and a Special Grant for the Prevention and Control of Infectious Diseases (No. 2009ZX10004‐204). None of the authors had any conflict of interest.

Acknowledgements

We should like to thank the entire staff of the Department of Respiratory Medicine, Children’s Hospital, Chongqing Medical University for their assistance in collecting the specimens. We also appreciate Z. Wenlu’s technical assistance.

References

  • 1. Rawlinson WD , Waliuzzaman Z , Carter IW , Belessis YC , Gilbert KM , Morton JR . Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection . J Infect Dis 2003. ; 187 : 1314 – 1318 . [DOI] [PubMed] [Google Scholar]
  • 2. Lehtinen P , Jartti T , Virkki R et al. Bacterial coinfections in children with viral wheezing . Eur J Clin Microbiol Infect Dis 2006. ; 25 : 463 – 469 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bisgaard H , Hermansen MN , Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates . N Engl J Med 2007. ; 357 : 1487 – 1495 . [DOI] [PubMed] [Google Scholar]
  • 4. Nagayama Y , Tsubaki T , Toba T , Nakayama S , Ookusu K . Interleukin 4 (IL‐4) and IL‐8 levels in sputum taken from wheezy infants and young children in relevant to bacterial colonization . Allergol Int 2004. ; 53 : 387 – 388 . [Google Scholar]
  • 5. Murray PR , Bron EJO , Pfaller MA , Tenover FC , Yolken RH . Manual of clinical microbiology , 6th edn . Washington, DC : American Society for Microbiology; , 1980. . [Google Scholar]
  • 6. Murray PR , Washington JA . Microscopic and bacteriologic analysis of expectorated sputum . Mayo Clin Proc 1975. ; 506 : 339 – 344 . [PubMed] [Google Scholar]
  • 7. Allander T , Tammi MT , Eriksson M , Bjerkner A , Tiveljung‐Lindell A , Andersson B . Cloning of a human parvovirus by molecular screening of respiratory tract samples . Proc Natl Acad Sci USA 2005. ; 102 : 12891 – 12896 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Naghipour M , Cuevas LE , Bakhshinejad T , Dove W , Hart CA . Human bocavirus in Iranian children with acute respiratory infections . J Med Virol 2007. ; 79 : 539 – 543 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Van den Hoogen BG , de Jong JC , Groen J et al. A newly discovered human pneunurvirus isolated from young children with respiratory tract disease . Nat Med 2001. ; 7 : 719 – 724 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Dakhama A , Hegele RG , Laflamme G , Israël‐Assayag E , Cormier Y . Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis . Am J Respir Crit Care Med 1999. ; 159 : 1316 – 1322 . [DOI] [PubMed] [Google Scholar]
  • 11. Fan J , Henrickson KJ . Rapid diagnosis of human parainfluenza virus type 1 infection by quantitative reverse transcription‐PCREnzyme hybridization assay . J Clin Microbiol 1996. ; 34 : 1914 – 1917 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Karron RA , Froehlich L , Belshe RB , Belshe RB , Yolken RH . Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription‐PCR‐enzyme immunoassay . J Clin Microbiol 1994. ; 32 : 484 – 488 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Collins PL , Hill MG , Johnson PR . The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro . J Gen Virol 1990. ; 71 : 3015 – 3020 . [DOI] [PubMed] [Google Scholar]
  • 14. Aniansson G , Alm B , Andersson B et al. Nasopharyngeal colonization during the first year of life . J Infect Dis 1992. ; 165 : S38 – S42 . [DOI] [PubMed] [Google Scholar]
  • 15. Faden H , Harabuchi Y , Hong JJ . Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media . J Infect Dis 1994. ; 169 : 1312 – 1317 . [DOI] [PubMed] [Google Scholar]
  • 16. Lundgren K , Ingvarsson L . Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy . Drugs 1986. ; 31 : 125 – 131 . [DOI] [PubMed] [Google Scholar]
  • 17. Vaneechoutte M , Verschraegen G , Claeys G , Weise B , Van Den Abeele AM . Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum . J Clin Microbiol 1990. ; 28 : 2674 – 2680 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Van Hare GF , Shurin PA , Marchant CD et al. Acute otitis media caused by Branhamella catarrhalis: biology and therapy . Rev Infect Dis 1987. ; 9 : 16 – 27 . [DOI] [PubMed] [Google Scholar]
  • 19. Sly PD , Hibbert ME . Childhood asthma following hospitalization with acute viral bronchiolitis in infancy . Pediatr Pulmonol 1989. ; 7 : 153 – 158 . [DOI] [PubMed] [Google Scholar]
  • 20. Friedman R , Ackerman M . Asthma and bacterial sinusitis in children . J Allergy Clin Immunol 1984. ; 72 : 185 – 189 . [DOI] [PubMed] [Google Scholar]
  • 21. Fagon JY , Chastre J . Severe exacerbations of COPD patients: the role of pulmonary infections . Semin Respir Infect 1996. ; 11 : 109 – 118 . [PubMed] [Google Scholar]
  • 22. Nicotra MB , Kronenberg RS . Con: antibiotic use in exacerbations of chronic bronchitis . Semin Respir Infect 1993. ; 8 : 254 – 258 . [PubMed] [Google Scholar]
  • 23. Tager I , Speizer FE . Role of infection in chronic bronchitis . N Engl J Med 1975. ; 292 : 563 – 571 . [DOI] [PubMed] [Google Scholar]
  • 24. Bisgaard H , Nielsen KG . Plethysmographic measurements of specific airway resistance in young children . Chest 2005. ; 128 : 355 – 362 . [DOI] [PubMed] [Google Scholar]
  • 25. Nielsen KG , Bisgaard H . Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years . Am J Respir Crit Care Med 2001. ; 164 : 554 – 559 . [DOI] [PubMed] [Google Scholar]
  • 26. Gu XX , Tsai CM , Apicella MA , Lim DJ . Quantitation and biological properties of released and cell‐bound lipooligosaccharides from nontypeable Haemophilus influenzae . Infect Immun 1995. ; 63 : 4115 – 4120 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Murawski MR , Bowen GN , Cerny AM et al. Respiratory syncytial virus activates innate immunity through toll‐like receptor 2 . J Virol 2009. ; 83 : 1492 – 1500 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Panuska JR , Merolla R , Rebert NA et al. Respiratory syncytial virus induces interleukin‐10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity . J Clin Invest 1995. ; 96 : 2445 – 2453 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Becker S , Quay J , Soukup J . Cytokine (tumor necrosis factor, IL‐6, and IL‐8) production by respiratory syncytial virus‐infected human alveolar macrophages . J Immunol 1991. ; 147 : 4307 – 4312 . [PubMed] [Google Scholar]
  • 30. Duttweiler L , Nadal D , Frey B . Pulmonary and systemic bacterial co‐infections in severe RSV bronchiolitis . Arch Dis Child 2004. ; 89 : 1155 – 1157 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Marzena EK , Jay YW , Hong WC et al. Persistent wheezing in very young children is associated with lower respiratory inflammation . Am J Respir Crit Care Med 2001. ; 163 : 1338 – 1343 . [DOI] [PubMed] [Google Scholar]
  • 32. McNamara PS , Flanagan BF , Hart CA , Smyth RL . Production of chemokines in the lungs of infants with severe RSV bronchiolitis . J Infect Dis 2005. ; 191 : 1225 – 1232 . [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology and Infection are provided here courtesy of Wiley

RESOURCES